Figure 4From: Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarkerKaplan-Meier survival analyses. Distant metastasis free survival of the 220 male breast cancer patients included in the TMA stratified by HLA expression (A) and NAT1 expression (B), respectively. The numbers below the plots indicate the number of patients at risk in each group at the given time points.Back to article page